Boukerche and colleagues [3,15] found that syntenin could increase FAK, JNK and p38 MAP kinase activity, as well as activation of nuclear factor-kappaB (NF-κB), all of which play an important role in syntenin-mediated anchorage-independent growth and motility in melanoma. The gene discussed is SDCBP; the disease is melanoma.